Evidence map›Paper›PMID 29628042›Full record

SynthesisBiological psychiatry2018

A Comprehensive Analysis of Nuclear-Encoded Mitochondrial Genes in Schizophrenia.

Vanessa F Gonçalves, Carolina Cappi, Christian M Hagen, Adolfo Sequeira, Marquis P Vawter, Andriy Derkach, Clement C Zai, Paula L Hedley, Jonas Bybjerg-Grauholm, Jennie G Pouget and 5 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Biological psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 5 countries.

Vanessa F GonçalvesDepartment of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Neuroscience Section, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. Electronic address: Vanessa.Goncalves@camh.ca.
Carolina CappiDepartment of Psychiatry, School of Medicine, University of São Paulo, São Paulo, Brazil.
Christian M HagenDepartment for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.
Adolfo SequeiraDepartment of Psychiatry and Human Behavior, University of California, Irvine, California.
Marquis P VawterDepartment of Psychiatry and Human Behavior, University of California, Irvine, California.
Andriy DerkachDepartment of Statistical Sciences, Faculty of Arts and Science, University of Toronto, Toronto, Ontario, Canada.
Clement C ZaiDepartment of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Neuroscience Section, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Paula L HedleyDepartment for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.
Jonas Bybjerg-GrauholmDepartment for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.
Jennie G PougetDepartment of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Neuroscience Section, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Ari B CuperfainDepartment of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Neuroscience Section, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Patrick F SullivanDepartment of Genetics, University of North Carolina, Chapel Hill, North Carolina; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Michael ChristiansenDepartment for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark; Department of Biomedical Science, University of Copenhagen, Copenhagen, Denmark.
James L KennedyDepartment of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Neuroscience Section, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Lei SunDepartment of Statistical Sciences, Faculty of Arts and Science, University of Toronto, Toronto, Ontario, Canada; Biostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Centre for Addiction and Mental Health · CAStatens Serum Institut · DKUniversity of California, Irvine · USUniversity of Toronto · CAUniversidade de São Paulo · BRUniversity of North Carolina at Chapel Hill · US

Funding

A Large-Scale Schizophrenia Association Study in SwedenR01MH077139 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SULLIVAN, PATRICK F · 2007 to 2018
$9.9M
Mitochondrial Dysfunction In SchizophreniaR01MH085801 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI VAWTER, MARQUIS PHILIP · 2009 to 2020
$5.0M
Metallothioneins and polyamines in major depression and suicideR01MH097082 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI SEQUEIRA, ADOLFO · 2012 to 2015
$1.5M
Mitochondrial Deletions in Mood DisordersR21MH099440 · NIMH · UNIVERSITY OF CALIFORNIA-IRVINE · PI VAWTER, MARQUIS PHILIP · 2013 to 2014
$424k
NIMH NIH HHS R01 MH077139NIMH NIH HHS R01 MH085801NIMH NIH HHS R01 MH097082NIMH NIH HHS R21 MH099440
6 · The paper itself

Abstract

backgroundThe genetic risk factors of schizophrenia (SCZ), a severe psychiatric disorder, are not yet fully understood. Multiple lines of evidence suggest that mitochondrial dysfunction may play a role in SCZ, but comprehensive association studies are lacking. We hypothesized that variants in nuclear-encoded mitochondrial genes influence susceptibility to SCZ.

methodsWe conducted gene-based and gene-set analyses using summary association results from the Psychiatric Genomics Consortium Schizophrenia Phase 2 (PGC-SCZ2) genome-wide association study comprising 35,476 cases and 46,839 control subjects. We applied the MAGMA method to three sets of nuclear-encoded mitochondrial genes: oxidative phosphorylation genes, other nuclear-encoded mitochondrial genes, and genes involved in nucleus-mitochondria crosstalk. Furthermore, we conducted a replication study using the iPSYCH SCZ sample of 2290 cases and 21,621 control subjects.

resultsIn the PGC-SCZ2 sample, 1186 mitochondrial genes were analyzed, among which 159 had p values < .05 and 19 remained significant after multiple testing correction. A meta-analysis of 818 genes combining the PGC-SCZ2 and iPSYCH samples resulted in 104 nominally significant and nine significant genes, suggesting a polygenic model for the nuclear-encoded mitochondrial genes. Gene-set analysis, however, did not show significant results. In an in silico protein-protein interaction network analysis, 14 mitochondrial genes interacted directly with 158 SCZ risk genes identified in PGC-SCZ2 (permutation p = .02), and aldosterone signaling in epithelial cells and mitochondrial dysfunction pathways appeared to be overrepresented in this network of mitochondrial and SCZ risk genes.

conclusionsThis study provides evidence that specific aspects of mitochondrial function may play a role in SCZ, but we did not observe its broad involvement even using a large sample.

Indexed as

Genes, MitochondrialGenetic Predisposition to DiseaseGenome-Wide Association StudyAdolescentAdultAgedFemaleHumansMaleMiddle AgedSchizophreniaYoung AdultGene-gene interactionGWAS-HDMAGMAMitochondriaOxidative phosphorylationSchizophreniaStratified FDR

Identifiers

PMID29628042
PMCPMC7168759
OpenAlexW2790717817

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.